Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Herboheal Jaddad is a natural topical ointment developed by Munir Sukhtian Pharmaceuticals, primarily indicated for the management of wounds, burns, and skin ulcers. The formulation is derived from traditional herbal medicine, featuring active extracts from *Alkanna tinctoria* (Alkanet) root and *Sesamum indicum* (Sesame) oil. It facilitates the healing process by maintaining a moist wound environment, which is essential for tissue regeneration and epithelialization. The active constituents, such as alkannin and shikonin, provide anti-inflammatory, antimicrobial, and antioxidant properties, helping to reduce pain and prevent infection while stimulating the repair of damaged skin. It is approved and widely marketed in the Middle East for various dermatological injuries, including diabetic foot ulcers and pressure sores.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Herboheal Jaddad.